RONCA, VINCENZO
 Distribuzione geografica
Continente #
AS - Asia 1.100
NA - Nord America 818
EU - Europa 178
SA - Sud America 155
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.281
Nazione #
US - Stati Uniti d'America 770
SG - Singapore 619
CN - Cina 260
BR - Brasile 121
VN - Vietnam 91
HK - Hong Kong 36
IT - Italia 33
CA - Canada 25
FR - Francia 20
GB - Regno Unito 18
DE - Germania 17
AR - Argentina 13
IN - India 12
MX - Messico 12
FI - Finlandia 11
BD - Bangladesh 10
CZ - Repubblica Ceca 10
EC - Ecuador 10
PL - Polonia 10
JP - Giappone 9
SA - Arabia Saudita 9
IE - Irlanda 8
NL - Olanda 8
IQ - Iraq 7
SE - Svezia 7
UA - Ucraina 7
ZA - Sudafrica 7
EG - Egitto 5
ID - Indonesia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
CO - Colombia 3
ES - Italia 3
GR - Grecia 3
PH - Filippine 3
PK - Pakistan 3
RU - Federazione Russa 3
AL - Albania 2
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.281
Città #
Singapore 288
San Jose 153
Ashburn 152
Shanghai 106
The Dalles 87
Beijing 61
Ho Chi Minh City 32
Hong Kong 32
Dallas 31
Los Angeles 31
Santa Clara 24
Boardman 22
New York 20
Hanoi 18
Montreal 12
Helsinki 11
São Paulo 10
Seattle 9
Warsaw 9
Brno 8
Buffalo 8
Dublin 8
Truccazzano 7
Amsterdam 6
Brooklyn 6
Da Nang 6
Johannesburg 6
Riyadh 6
Tokyo 6
Chicago 5
Stockholm 5
Assago 4
Baghdad 4
Benin City 4
Campinas 4
Frankfurt am Main 4
Mexico City 4
Milan 4
Munich 4
Ottawa 4
Phoenix 4
Quito 4
Biên Hòa 3
Boston 3
Cairo 3
Charlotte 3
Council Bluffs 3
Denver 3
Dhaka 3
Dorridge 3
Giugliano in Campania 3
Haiphong 3
Hangzhou 3
Hillsboro 3
Hải Dương 3
Lawrence 3
London 3
Naples 3
Orem 3
Porto Alegre 3
Princeton 3
Pune 3
Rio de Janeiro 3
Rome 3
San Francisco 3
Secaucus 3
São Bernardo do Campo 3
Ambato 2
Ankara 2
Athens 2
Atlanta 2
Bishkek 2
Brasília 2
Bucharest 2
Budrio 2
Buenos Aires 2
Campos dos Goytacazes 2
Can Tho 2
Changsha 2
Chennai 2
Cipolletti 2
City of London 2
Colombo 2
Conselheiro Lafaiete 2
Curitiba 2
Dubai 2
Fortaleza 2
Go Vap 2
Greensboro 2
Jeddah 2
Kyiv 2
Lisbon 2
Maceió 2
Manchester 2
Marseille 2
Mauá 2
Nairobi 2
Oslo 2
Panama City 2
Panipat 2
Totale 1.370
Nome #
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement 98
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 90
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 82
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 71
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis 66
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation 66
Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer 60
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 57
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 56
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy 56
Ex situ Normothermic Split Liver Machine Perfusion: Protocol for Robust Comparative Controls in Liver Function Assessment Suitable for Evaluation of Novel Therapeutic Interventions in the Pre-clinical Setting 55
Breakdown in hepatic tolerance and its relation to autoimmune liver diseases 52
Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 51
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 50
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 49
Toward precision medicine in primary biliary cholangitis 49
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis 49
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 49
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 49
Epidemiology and predictors of splanchnic thrombosis in liver transplant candidates: a single centre study 48
Assessment of advanced age candidates for liver transplantation warrants more caution 48
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 47
Is ChatGPT a reliable tool in Autoimmune Hepatitis? 47
Prognostic models in primary biliary cholangitis 46
Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells 46
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 45
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 45
New Therapeutic Targets in Autoimmune Cholangiopathies 44
Conversion of CD4+T cells to functioning and epigenetically stable induced regulatory T cells in patients with primary biliary cholangitis 44
Donation after Circulatory Death Liver Transplantation in Paediatric Recipients 43
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 43
Type 2 Autoimmune Hepatitis and Nonadherence to Medication Correlate With Premature Birth and Risk of Postpartum Flare 42
Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 42
The Human Immune Response to Cadaveric and Living Donor Liver Allografts 41
The Immunological Basis of Liver Allograft Rejection 41
Precision medicine in primary biliary cholangitis 41
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 40
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 39
Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 38
Use of immunosuppression in non-transplant hepatology 37
Organ Restoration With Normothermic Machine Perfusion and Immune Reaction 37
An “unmodifiable” risk factor that has been modified 37
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison 36
The invasion of the biliary epithelial cells by CD103+ CD69+ in-traepithelial cells CD8+ T lymphocyte and its role in the patho-genesis of primary biliary cholangitis 34
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 33
Reply to: "A spotlight on natural killer cells in primary biliary cholangitis" 32
Moving Forward to New Trends in Liver Transplantation 29
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 29
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects 3
Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment 3
From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis 1
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis 1
Totale 2.337
Categoria #
all - tutte 14.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 0 0 0 0 5 0 8 0
2022/202322 7 1 4 0 2 0 0 0 2 4 2 0
2023/2024241 3 2 6 2 1 4 82 13 11 6 43 68
2024/2025594 17 5 8 11 6 92 36 62 84 138 74 61
2025/20261.467 224 73 52 113 88 78 406 91 79 89 101 73
Totale 2.337